Wu learned that the board of directors of BioNexus Gene Lab, a medical technology company, has approved a financial reserve strategy centered around Ethereum (ETH), becoming the first Nasdaq listed company to focus on Ethereum. BGLC also released the "Ethereum Strategy White Paper", elaborating on the basis of this decision and analyzing the role of Ethereum in institutional adoption, Proof of Stake (PoS) staking benefits, stablecoin trading, and the upcoming Pectra protocol upgrade. https://www. (wublock123.com)/index.php? m=content&c=index&a=show&catid=6&id=38974